Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of HLA evolutionary divergence on clinical features of patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria
    Meeting Abstract

    Pagliuca, S.; Gurnari, C.; Chowell, D.; Krishna, C.; Patel, B. J.; Awada, H.; Kerr, C. M.; Kongkiatkamon, S.; Kishtagari, A.; Laframboise, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Targeted integration of a CAR at a novel genomic safe harbor directs potent therapeutic outcomes
    Meeting Abstract

    Odak, A.; Yuan, H.; Feucht, J.; Mansilla-Soto, J.; Eyquem, J.; Leslie, C.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • Infusion-related reactions (IRRs) in the DREAMM-2 Study of single-agent belantamab mafodotin (belamaf) in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nooka, A.; Lee, H. C.; Badros, A. Z.; Voorhees, P.; Hultcrantz, M.; Karlin, L.; Arnulf, B.; Richardson, P. G.; Zhi, E.; Baron, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center, dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of a novel IRAK4 inhibitor CA-4948 in combination with ibrutinib, in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Joffe, E.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Mead, M.; Landsburg, D. J.; Fenske, T. S.; Ramchandren, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single-cell multi-omics in human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
    Meeting Abstract

    Nam, A. S.; Dusaj, N.; Izzo, F.; Murali, R.; Mouhieddine, T. H.; Myers, R. M.; Sotelo, J.; Benbarche, S.; Gaiti, F.; Tahri, S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Post-treatment clone size predicts survival independently of IPSS-R and response after azacitidine therapy for MDS
    Meeting Abstract

    Nannya, Y.; Tobiasson, M.; Sato, S.; Bernard, E.; Creignou, M.; Zhao, L.; Takeda, J.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Transcriptional control of HP1a by the RNA binding proteins RBMX/L1 maintain chromatin state in myeloid leukemia
    Meeting Abstract

    Nguyen, D. T. T.; Prieto, C.; Liu, Z.; Wheat, J.; Perez, A.; Gourkanti, S.; Chou, T.; Barin, E.; Chow, A.; Taggart, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET
    Meeting Abstract

    Mondello, P.; Strati, P.; Merryman, R. W.; Joffe, E.; Ruella, M.; Seshan, V.; St Pierre, F.; Major, A.; Pophali, P.; Fiasconaro, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save